Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label, Active-controlled, Randomized Study Comparing Nifedipine GITS Versus Valsartan Versus a Combination of Both on Central Blood Pressure in Inadequately Controlled Essential Hypertension.

NCT01071122 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01071122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01071122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label, Active-controlled, Randomized Study Comparing Nifedipine GITS Versus Valsartan Versus a Combination of Both on Central Blood Pressure in Inadequately Controlled Essential Hypertension.
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
February 29, 2012
Enrollment
365 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension